# Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19

> **NCT04469153** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 57 (estimated)

## Conditions studied

- the Prognostic Value of Ferritin
- Glycosylated Ferritin in SARS-CoV-2 Infection in Hospitalized COVID-19 Patients

## Interventions

- **OTHER:** No intervention / Evaluation of the ferritin and glycosylated ferritin by standard approved serological tests

## Key facts

- **NCT ID:** NCT04469153
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-29
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-12-31
- **Target enrollment:** 57 (ESTIMATED)
- **Last updated:** 2020-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04469153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04469153, "Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04469153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*